Seclaris DC 250 mg Intramammary Suspension for dry cows
Seclaris DC 250 mg Intramammary Suspension for dry cows
Authorised
- Cefalonium dihydrate
Product identification
Medicine name:
SECLARIS DC 250 MG INTRAMAMMARY SUSPENSION FOR DRY COWS
Seclaris DC 250 mg Intramammary Suspension for dry cows
Active substance:
- Cefalonium dihydrate
Target species:
-
Cattle (cow)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Cefalonium dihydrate269.60/milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
- Cattle (cow)
-
Milk96hour96 hours after calving if the dry period is longer than 54 days
-
Meat and offal21day
-
Milk58day58 days following the treatment if the dry period is less than or equal to 54 days
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51DB90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Ireland
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
- Lohmann Pharma Herstellung GmbH
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA10815/047/001
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0399/001
Concerned member states:
-
Austria
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Estonia
-
Germany
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?:
